ANTONIO
OSUNA ORTEGA
COLABORADOR EXTRAORDINARIO
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Miguel Servet (4)
2022
-
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study
Clinical transplantation, Vol. 36, Núm. 3, pp. e14550
2018
-
Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial
American Journal of Transplantation, Vol. 18, Núm. 4, pp. 927-935
2015
-
Medium-Term Renal Function in a Large Cohort of Stable Kidney Transplant Recipients Converted from Twice-Daily to Once-Daily Tacrolimus
Transplantation Direct, Vol. 1, Núm. 7, pp. E24
2011
-
Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients
American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971